Advertise on podcast: Taking Control Of Your Diabetes® - The Podcast!

Dr. Steve Edelman and Dr. Jeremy Pettus discuss how GLP-1 medications have evolved and where they may be headed next. They look back at the progression from early twice-daily injections to once-weekly therapies and explain how the role of GLP-1s has expanded from managing glucose to supporting weight management, cardiovascular health, kidney health, and other areas of metabolic health. The conversation explores newer oral GLP-1 options and what taking a pill instead of an injection could mean for people who prefer that option. Dr. Edelman and Dr. Pettus also discuss the next generation of therapies that combine GLP-1 with hormones such as glucagon and amylin. They explain why researchers are combining these different hormones, how they may affect weight and glucose, and why getting to the highest possible dose isn’t necessarily the goal for everyone. They also address some of the practical questions that come with taking a GLP-1, including side effects, cost, insurance coverage, and whether these medications need to be taken long term. The discussion covers nausea and other GI side effects, concerns about losing muscle and lean mass during significant weight loss, and why getting enough protein and staying physically active can be important. They also explain what can happen when GLP-1 therapy is stopped, including the possibility of regaining weight. Finally, Dr. Edelman and Dr. Pettus discuss what GLP-1 medications could mean for people living with type 1 diabetes. They share their clinical experience using these medications in people with type 1 diabetes for other indications and discuss ongoing research looking at their potential effects on weight, insulin needs, A1C, and glucose variability. They also look at how future approvals could affect insurance coverage and what continued innovation may mean for people living with diabetes. ★ Support this podcast ★

What if you could take your basal insulin once a week instead of every day? Once-weekly basal insulin has arrived, offering a new approach that could make insulin therapy simpler while providing glucose control comparable to daily basal insulin. In this episode, Dr. Steve Edelman is joined by Dr. Athena Philis-Tsimikas, a leading diabetes researcher who has been directly involved in clinical trials of once-weekly basal insulins. Together, they explain how these ultra-long-acting insulins work, how a single injection can provide steady background insulin throughout an entire week, and what studies have shown when once-weekly insulin is compared with traditional daily basal insulin. The conversation gets practical with how once-weekly insulin is started, adjusted, and switched from daily basal insulin. Dr. Edelman and Dr. Philis-Tsimikas discuss the dosage differences with once-weekly basal insulin, how concentrated insulin keeps the actual injection volume small, and how fasting glucose can help guide dose adjustments. They also discuss what happens if you miss a dose and why reaching a steady state is an important part of understanding how these longer-acting insulins work. They also dive into the clinical trial results, including A1C, time in range, and hypoglycemia. In studies of people living with type 2 diabetes, once-weekly basal insulin provided similar A1C lowering to daily basal insulin without an increase in hypoglycemia. They also explain why the story is different for people living with type 1 diabetes, where studies found higher rates of hypoglycemia with weekly basal insulin, and what that means for its use in the United States. Finally, Dr. Edelman and Dr. Philis-Tsimikas look at how once-weekly insulin could make diabetes management easier. Going from seven basal injections a week to just one could help reduce some of the daily burden of diabetes and make it easier to consistently take your insulin. They also explore using weekly insulin alongside GLP-1 medications, potential combination therapies, cost and access, and what we still need to learn as these newer insulins move from clinical trials into everyday diabetes care. Key Topics: How once-weekly basal insulin worksOnce-weekly vs. daily basal insulinStarting, dosing, and adjusting weekly insulinWhy weekly insulin doses may look surprisingly largeA1C, time in range, and hypoglycemia resultsWhat to do if you miss a weekly doseOnce-weekly insulin in type 1 vs. type 2 diabetesWho may benefit from once-weekly insulin?Reducing the burden of daily injectionsUsing once-weekly insulin with GLP-1 medicationsFuture insulin and GLP-1 combination therapiesCost, access, and real-world considerationsWhat the future of basal insulin could look likeThis episode was supported by Lilly. ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram:   / tcoydFacebook:   / tcoyd Stay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

Managing type 2 diabetes can change over time, but having the right information for your patients can make those changes feel a lot more manageable. CGM can help your patients see what’s happening with their blood sugar and guide what comes next. In this episode of the TCOYD Podcast, Dr. Steve Edelman and Dr. Jeremy Pettus discuss how continuous glucose monitoring is changing the way type 2 diabetes is managed for your patients, especially as treatment needs evolve over time. They explain why type 2 diabetes can progress from lifestyle changes and oral medications to GLP-1 therapies and insulin, and why needing insulin isn’t a personal failure. They also explore how seeing glucose data in real time can help your patients better understand how meals, exercise, medications, and insulin affect their glucose throughout the day. The conversation gets practical with how CGM can help guide your patients’ transition to basal insulin, make insulin adjustments easier and safer, and identify when mealtime insulin may be needed. Dr. Edelman and Dr. Pettus explain what overnight glucose patterns can tell you about your patients’ basal insulin dose, how to recognize post-meal spikes, and why starting mealtime insulin doesn’t necessarily mean adding injections at every meal for your patients. They also discuss newer basal insulins, avoiding too much basal insulin, and how automated insulin delivery systems may fit into the future of type 2 diabetes management. Ultimately, CGM gives your patients living with type 2 diabetes more than glucose numbers. It provides feedback that can help them recognize patterns, see how their treatment is working, and work with their healthcare team to make more informed adjustments as their diabetes management needs change. Key Topics: Why type 2 diabetes treatment needs can change over timeHow insulin resistance and declining insulin production affect glucose managementWhy needing insulin is not a personal failureHow CGM use is expanding in type 2 diabetesUsing CGM with lifestyle changes, oral medications, GLP-1 therapies, and insulinWhat time in range, GMI, and glucose variability can tell youHow CGM can help determine when basal insulin may be neededUsing overnight glucose patterns to adjust basal insulinWhy insulin titration matters more than the initial starting doseHow CGM can make insulin adjustments easier and saferWhen mealtime insulin may be neededWhy mealtime insulin doesn’t always have to be taken with every mealHow to recognize and avoid too much basal insulinThe benefits of newer long-acting basal insulinsWhen patients with type 2 diabetes may want to consider an insulin pump or automated insulin delivery systemHow real-time glucose feedback can help people take a more active role in their diabetes management✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram:   / tcoydFacebook:   / tcoyd Stay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

Chronic kidney disease (CKD) is one of the most common complications of diabetes, but here’s the tricky part: you can have it for years without feeling any symptoms. The good news? Kidney disease can often be detected early, and with the right screening, treatments, and lifestyle changes, its progression can be dramatically slowed.  In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus are joined by nephrologist Dr. Bethany Karl to break down what everyone with diabetes should know about kidney health. Dr. E also steps into the patient seat to share his own experience living with chronic kidney disease, from discovering it without symptoms to navigating kidney tests and newer treatments. Together, they explain the two simple tests that can uncover kidney problems, why blood pressure and cardiovascular health matter, and how today’s growing toolbox of medications is giving people with diabetic kidney disease more reasons for hope. Key Topics: Why chronic kidney disease is often a “silent” complication of diabetesHow diabetes can affect the kidneys over timeDr. Edelman’s personal experience with diabetic kidney diseaseThe two important kidney tests: eGFR and UACRWhy urine protein can be an important early warning signHow often people with diabetes should have their kidneys screenedThe connection between glucose, blood pressure, cholesterol, heart health, and kidney healthLifestyle considerations for protecting kidney functionMedications that can help slow the progression of diabetic kidney diseaseNewer kidney-protective therapies and why there is more reason for optimism today✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram:   / tcoydFacebook:   / tcoyd Stay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

Hot flashes, blood sugar swings, brain fog... is it menopause, diabetes, or both? In this episode of the TCOYD Podcast, Dr. Steve Edelman is joined by renowned menopause expert Dr. Cindy Stuenkel, endocrinologist and Professor Emerita at UC San Diego, for an insightful conversation about how menopause affects women living with diabetes. Together, they explain why menopause is much more than a normal stage of aging. It's a major metabolic transition that can influence blood sugar management, insulin resistance, heart health, sleep, mood, and overall quality of life.  The conversation explores what actually happens during perimenopause, menopause, and postmenopause, why hormonal fluctuations can make glucose management more challenging, and how continuous glucose monitoring can help distinguish hot flashes from hypoglycemia. Dr. Edelman and Dr. Stuenkel also discuss the latest evidence on hormone replacement therapy, newer non-hormonal treatment options, the importance of protecting heart health, and practical strategies to help women navigate this stage of life with greater confidence. Whether you're living with type 1 or type 2 diabetes, approaching menopause, currently experiencing it, or supporting someone who is, this episode provides practical guidance and evidence-based information to help you feel more prepared.  Key Topics: What is perimenopause, menopause, and postmenopause?How hormonal changes affect blood sugar and insulin resistanceWhy menopause can increase glucose variability in women with diabetesThe difference between hot flashes and hypoglycemiaHow continuous glucose monitoring can help during menopauseMetabolic changes that occur during the menopause transitionWhy cardiovascular risk increases after menopauseThe connection between menopause, weight gain, and abdominal fatGLP-1 medications and menopauseThe latest recommendations on hormone replacement therapyNew non-hormonal treatments for hot flashesSleep, mood, brain fog, and quality of life during menopauseHeart health strategies for women living with diabetesHow partners can better support someone going through menopauseTrusted menopause resources and when to seek medical care✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram:   / tcoydFacebook:   / tcoyd Stay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

Have you or someone you know been diagnosed with type 2 diabetes, only to discover later it was actually type 1? You're not alone. In this episode of the TCOYD Podcast, Dr. Steve Edelman is joined by Dr. Schaefer Boeder, endocrinologist, Medical Director of Paradigm Research, Associate Professor at UCSD, for an eye-opening discussion about LADA (Latent Autoimmune Diabetes in Adults)—one of the most commonly misdiagnosed conditions in diabetes. Together, they explain why so many adults are initially misdiagnosed with type 2 diabetes despite the warning signs that should raise suspicion for LADA, and why getting the correct diagnosis can dramatically change treatment and long-term outcomes. The conversation explores how LADA differs from both classic type 1 and type 2 diabetes, why the autoimmune process develops more slowly, and when antibody testing should be considered. Dr. Edelman and Dr. Boeder also discuss the importance of preserving beta cell function, the role of continuous glucose monitoring, advances in disease-modifying therapies, and why there has never been a more exciting time for research in adults who developed type 1 diabetes later in life. Whether you've been diagnosed with LADA, care for someone who has, or simply want to better understand adult-onset autoimmune diabetes, this episode provides practical guidance and hope for more accurate diagnoses in the future. Key Topics: What is LADA (Latent Autoimmune Diabetes in Adults)?Why LADA is so often mistaken for type 2 diabetesCommon signs that may point to a misdiagnosisHow LADA differs from classic type 1 and type 2 diabetesWhy many adults don't fit the "typical" diabetes profileAutoantibody testing and when it should be consideredThe role of GAD antibodies and C-peptide testingWhy preserving beta cell function mattersPreventing diabetic ketoacidosis (DKA) through earlier diagnosisHow continuous glucose monitoring can ease the transition to insulinCurrent treatment approaches for adults with LADAThe latest research on disease-modifying therapies and preserving insulin productionScreening resources, clinical trials, and where the future of LADA research is headed✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram:   / tcoydFacebook:   / tcoyd Stay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus are joined by Dr. Shara Bialo, Senior Medical Director of Type 1 Diabetes Immunology at Sanofi, pediatric endocrinologist, and person living with type 1 diabetes, for an in-depth discussion about what happens before type 1 diabetes is diagnosed. Together, they explore the autoimmune process that begins months or even years before symptoms appear, why early detection matters, and how screening is changing the future of type 1 diabetes care.  Dr. Bialo shares her personal diagnosis story, discusses common misconceptions about what causes type 1 diabetes, and explains the three stages of the disease. The conversation also covers who should be screened, how diabetes autoantibody testing works, the benefits of preserving beta cell function, and why identifying people before they develop symptoms can lead to better long-term outcomes and fewer cases of diabetic ketoacidosis (DKA). Whether you have type 1 diabetes, have a family member at risk, or simply want to better understand the latest advances in prevention and early detection, this episode provides valuable insights into one of the fastest-moving areas of diabetes research. Key Topics: Dr. Shara Bialo's personal journey living with type 1 diabetesWhy type 1 diabetes is an autoimmune disease, not simply a blood sugar problemThe role of genetics, viral infections, and the immune systemUnderstanding the three stages of type 1 diabetesWhy most people diagnosed with type 1 diabetes have no family historyAdult-onset type 1 diabetes and why it is often mistaken for type 2 diabetesWhat diabetes autoantibodies are and how screening worksWho should consider screening for type 1 diabetesAvailable screening options, including blood tests and home screening kitsThe emotional challenges families face when considering screeningThe importance of preventing diabetic ketoacidosis through early detectionWhy preserving beta cell function can improve long-term outcomesItaly's national screening program and the future of population-wide screeningResources available through screenfortype1.comThis content was produced with support from Sanofi and screenfortype1.com. ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram:   / tcoydFacebook:   / tcoyd Stay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

In this episode of the TCOYD Podcast, Dr. Steve Edelman is joined by Raquel Baron, founder of Type One Together, to discuss the challenges, triumphs, and everyday realities of raising a child with type 1 diabetes. Diagnosed herself at age five, Raquel combines her lived experience with years of supporting families through Type One Together, an organization that provides trusted resources, educational programs, and a nationwide network of trained babysitters for children with type 1 diabetes.  Together, Dr. Edelman and Raquel explore the emotional side of diabetes that often goes beyond blood sugars. They discuss helping children navigate school, sports, friendships, burnout, and growing independence, while giving parents practical strategies to reduce fear, build confidence, and create a healthier relationship with diabetes. The conversation also covers diabetes technology, social media, Afrezza for children, community support, and why perfection should never be the goal. Whether you’re the parent of a newly diagnosed child or have been managing type 1 diabetes for years, this episode offers practical advice, reassurance, and reminders that children with diabetes can live full, active lives. ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram:   / tcoydFacebook:   / tcoyd Stay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

In this episode of the TCOYD Podcast, Dr. Steve Edelman is joined by pediatric endocrinologist Dr. Anna Cymbaluk, along with Philip and his father Jim, to discuss the recent FDA approval of Afrezza inhaled insulin for children and adolescents living with type 1 diabetes. Dr. Cymbaluk served as an investigator on the INHALE-1 trial, while Philip participated in the study himself, providing a unique real-world perspective on what it is like to transition from injections to inhaled insulin, and Philip’s dad, Jim provided the parent perspective as well as addressed parental concerns that might have arisen. The conversation focuses on the INHALE-1 study and the unmet challenges that continue to exist around mealtime insulin dosing in pediatric diabetes care. Dr. Cymbaluk reviews the trial design, glucose outcomes, safety data, patient satisfaction findings, and the practical realities of introducing inhaled insulin into everyday diabetes management. Philip and Jim share how Afrezza impacted school, sports, social situations, and the day-to-day burden of diabetes, particularly around pre-bolusing, corrections, and avoiding multiple injections throughout the day.Dr. Edelman and Dr. Cymbaluk also explore how Afrezza is dosed, how inhaled insulin differs from injected insulin, who may be a good candidate, and where it may fit alongside pumps and automated insulin delivery (AID) systems. For families looking for more flexibility, fewer mealtime barriers, and another option in the diabetes toolbox, this episode provides an honest look at the benefits, limitations, and real-world experience of inhaled insulin in children and teens. Key Topics• The FDA approval of Afrezza for children and adolescents living with type 1 diabetes• The design and results of the INHALE-1 pediatric clinical trial• Patient satisfaction and quality-of-life outcomes from the study• The challenges of pre-bolusing and mealtime insulin management in children and teens• How inhaled insulin compares to traditional mealtime injections• Dosing strategies, cartridge sizes, and insulin conversion considerations• Using Afrezza for corrections, meals, and post-meal dosing• The role of continuous glucose monitoring (CGM) when using inhaled insulin• Safety findings, lung-function monitoring, and cough management• Who may be a good candidate for Afrezza—and who may not be• Benefits for active children, athletes, and those participating in sports• Social situations, injection avoidance, and reducing the burden of diabetes management• Using Afrezza alongside insulin pumps and automated insulin delivery (AID) systems• The importance of having more treatment options to individualize diabetes care Supported by an unrestricted educational grant from MannKind Corporation Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives. More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram: / tcoydFacebook: / tcoydStay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

In this episode of the TCOYD Podcast, Drs. Edelman and Pettus are joined by pediatric endocrinologist Dr. Jamie Wood, medical director of pediatric diabetes at Rainbow Babies & Children's Hospital and an investigator on the INHALE-1 trial, to discuss inhaled insulin in children and its place in pediatric practice. The conversation centers on the recent approval of Afrezza down to age six and what INHALE-1 actually demonstrated. Dr. Wood walks through the trial design, the A1C analysis, the FEV1 and pulmonary safety data, the weight and BMI findings, and the practical mechanics of dosing in a pediatric population. Rather than framing it as a replacement for injections or automated insulin delivery (AID), the discussion focuses on where this option fits, from the needle-averse newly diagnosed patient, to the teen trying to bolus discreetly during a 20-minute lunch period. Drs. Edelman, Pettus, and Wood also get into the clinical realities that shape real-world use: the 2:1 to 3:1 conversion versus subcutaneous insulin, the set-dose cartridges and how they reframe carb counting, a refined titration approach, side effects, and how inhaled insulin can be layered alongside pumps and AID. For a population where mealtime bolusing remains one of the most stubborn unmet needs, it is a grounded look at a new tool and the patients it may help most. Key Topics  The recent approval of inhaled insulin for children as young as six How the INHALE-1 pediatric trial was designed A1C results and what the primary endpoint analysis showed Continuous glucose monitor (CGM) metrics across the two groupsLung-function (FEV1) monitoring and pediatric safety Weight and body mass index (BMI) findings Why mealtime dosing is a leading unmet need in pediatric type 1 diabetes (T1D) The set-dose cartridge approach and how it reframes meal sizes A real-world titration method for inhaled insulin Managing cough and other practical considerations Needle phobia and the kids who struggle most with injections Using inhaled insulin alongside automated insulin delivery (AID) systems What's coming next, including a smaller cartridge dose and a new-onset trialThis episode is supported by an unrestricted educational grant from MannKind Corporation. Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives. More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram: / tcoydFacebook: / tcoydStay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

What diabetes technology is actually helping people right now—and how do you figure out what fits best into your life? In this 100th episode of the TCOYD Podcast, Dr. E and Dr. P are joined by diabetes nurse practitioner and educator Rachael Sood, founder of The Diabetes Collective, to talk through the latest updates in diabetes technology and what they’re seeing in real-world diabetes care. The conversation focuses on how much diabetes technology has changed over the past few years, from hybrid closed loop systems and CGMs to new developments in sensing and automation. Rather than focusing on one “best” device, the discussion centers around finding the right fit for each person’s lifestyle, preferences, and goals. Dr. E, Dr. P, and Rachael also talk about where technology may be headed next, including dual glucose and ketone sensors, more compatibility between pumps and CGMs, and the possibility of systems that require less hands-on work from people living with diabetes. The takeaway is encouraging: there are more tools and options than ever before, and diabetes technology continues to move toward making daily management simpler, safer, and more flexible. Key Topics• Choosing the right insulin pump and CGM• Tubed vs. tubeless pump systems• How lifestyle and personal preference shape technology choices• The latest updates in automated insulin delivery systems• Dexcom G7 10-day vs. 15-day sensors• Abbott’s dual glucose and ketone sensor technology• Medtronic’s newest technology developments• Real-world conversations patients have about wearing devices• Continuous ketone monitoring and DKA prevention• The future of fully closed loop systems• Why compatibility between pumps and CGMs matters• Technology options for people with type 2 diabetes• Where diabetes technology may be headed next ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram:   / tcoydFacebook:   / tcoyd Stay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

What if something was going on with your health and you didn’t feel any symptoms at all? Could it be metabolic dysfunction-associated steatohepatitis (MASH)? In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus talk about fatty liver and MASH, a condition that can develop quietly but still has a real impact over time. They’re joined by patient advocate Manuel Oliver, who shares his experience after being diagnosed and what helped him turn things around.  They explain why fatty liver is so common, especially in people with metabolic conditions, and why it often goes unnoticed. The conversation also highlights how things can change over time, even when you feel okay, and why routine checkups matter. Manuel shares what it was like to hear his diagnosis, how it affected him, and the steps he took to improve his health. You’ll also hear how care has evolved, including better ways to detect liver disease and more options to support treatment alongside lifestyle changes. The message is simple: this condition can be serious, but there are ways to manage it, and taking action can make a meaningful difference.✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram:   / tcoydFacebook:   / tcoyd Stay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

What does it really mean to be “gluten-free” and how do you know if it’s something you actually need?In this episode, Dr. Steve Edelman sits down with registered dietitian EA Stewart (aka The Spicy RD) to talk through the difference between celiac disease and gluten sensitivity, and why that distinction matters. They explain how celiac disease develops, why it’s often missed, and how it connects to other autoimmune conditions like type 1 diabetes. This conversation helps make sense of a topic that can feel confusing. Dr. E and EA walk through symptoms that go beyond digestion, the importance of getting tested the right way, and what it means to truly follow a gluten-free diet.They also talk about the day-to-day side of things—how to approach food, avoid cross-contamination, and build a way of eating that works in real life.The main takeaway: not everyone needs to avoid gluten, but if you do, understanding the reason behind it can make it a lot more manageable Key Topics• What celiac disease is and how it differs from gluten sensitivity• The role of genetics, triggers, and gluten exposure• Why celiac disease is often undiagnosed• Common and less obvious symptoms• The connection between celiac disease and type 1 diabetes• How to properly test for celiac disease• Why you need to be eating gluten before testing• What a gluten-free diet actually looks like• Naturally gluten-free foods and better alternatives• Hidden sources of gluten in everyday foods• Cross-contamination and why it matters• Nutrient deficiencies and when supplements may help• Tips for eating out and traveling ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram:   / tcoydFacebook:   / tcoyd Stay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

What if a type 2 diabetes diagnosis could be the start of taking better care of your health—not the end of it? In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus share their top 10 tips for people newly diagnosed with type 2 diabetes, with a focus on helping you feel informed, supported, and encouraged. They talk about why this diagnosis is not a personal failure, how much of it is connected to genetics and metabolism, and why early understanding can make a meaningful difference. The conversation is grounded, hopeful, and focused on what’s possible. Steve and Jeremy walk through simple, realistic steps that can help you feel more in control—without pressure to be perfect. They cover everything from understanding how your body works to building habits that fit into your everyday life, along with the growing number of tools and treatments that can support you along the way. The takeaway is clear: this diagnosis can feel overwhelming at first, but it can also be a turning point. With time, support, and the right approach, you can improve your health and continue living a full, active life. Key Topics• Why type 2 diabetes is not your fault• Understanding insulin resistance and disease progression• Why early action matters• Focusing on weight with realistic expectations• The role of GLP-1 medications in early treatment• Exercise and movement as part of daily life• Learning how food affects your body• Using blood sugar monitoring in a practical way• Taking medications consistently• Protecting your heart early• The importance of routine screenings and labs• Building a strong and supportive care team ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram:   / tcoydFacebook:   / tcoyd Stay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

What does someone really need to know in the first days and weeks after a type 1 diabetes diagnosis? In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus share the “starter kit” they wish every newly diagnosed person and family had from the very beginning. Both diagnosed with type 1 diabetes at age 15, Steve and Jeremy reflect on what has changed since their own diagnoses and walk through the practical advice, emotional reassurance, and foundational education that can make this transition a little less overwhelming. The conversation covers everything from the normal emotional reaction to a diagnosis, to the importance of early diabetes education, getting started with insulin, using CGM as soon as possible, and setting realistic blood sugar goals. They also talk about the honeymoon phase, how to keep doing the things you love, why support systems matter, how to find the right provider, and what newly diagnosed families should know about clinical trials and preserving beta cell function. This episode is a reminder that while a new diagnosis can feel like your world has been turned upside down, people with type 1 diabetes can live long, healthy, full lives—and that no one has to figure it all out alone. Key Topics • Why it’s okay to feel overwhelmed after diagnosis • The importance of diabetes education right away • Understanding the honeymoon phase • Basal and bolus insulin basics • Why CGM should be started early • Realistic A1C and time-in-range goals • Keeping up with the things you love • Involving family, friends, and support networks • Finding the right diabetes provider • Considering clinical trials after diagnosis • Food, carb counting, and keeping things simple • Staying positive and looking ahead ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram:   / tcoydFacebook:   / tcoyd Stay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★